分类: health

  • Two possible Ebola cases in Brazil ruled out as patients test negative

    Two possible Ebola cases in Brazil ruled out as patients test negative

    Brazilian local health authorities have officially announced that two people who were once under monitoring as suspected Ebola cases have now cleared their tests, with both returning negative results for the deadly virus.

    The two suspected patients, who developed Ebola-compatible symptoms after returning from trip to African nations, were placed under observation and testing in Brazil’s two largest urban centers, São Paulo and Rio de Janeiro, immediately after they showed symptoms. According to an official announcement from São Paulo’s health department, the 37-year-old male patient, who had traveled to the Democratic Republic of the Congo (DRC) – the epicenter of the ongoing Ebola outbreak – did not contract Ebola. Subsequent tests revealed he was actually infected with meningitis, and had only presented fever, a common overlapping symptom for both diseases.

    In the separate case in Rio de Janeiro, the patient – a Belgian national who recently returned from Uganda – also tested negative for Ebola. He had been flagged for suspicion after showing viral symptoms including cough, body chills and diarrhea, but test results confirmed he was suffering from malaria instead.

    Health officials noted that if either of these two cases had returned positive Ebola results, they would have marked the first confirmed Ebola infections detected outside of Africa since the current outbreak took hold in the DRC.

    As of current reports, the outbreak situation in Africa remains serious. The DRC has recorded more than 1,000 suspected Ebola cases, with at least 246 confirmed deaths linked to the virus. Most infections are concentrated in three eastern provinces of the country: Ituri, North Kivu and South Kivu. Neighboring Uganda has also confirmed nine Ebola cases and one fatality from the disease.

    The ongoing outbreak is driven by the Bundibugyo strain, a rare Ebola variant for which no licensed, proven effective vaccine currently exists. This strain has an average mortality rate of roughly 30 percent among those who contract it. At present, three new candidate vaccines targeting the Bundibugyo strain are under active development, led by research teams including the International AIDS Vaccine Initiative (IAVI), the University of Oxford, and biopharmaceutical company Moderna.

    For background, Ebola viruses are primarily zoonotic pathogens that naturally circulate in wild animal populations, most commonly fruit bats. Human outbreaks typically originate when an individual comes into contact with or consumes an infected animal. Once an initial human infection occurs, the virus spreads rapidly through direct contact with an infected person’s bodily fluids – which includes sweat, saliva, blood, semen, feces, urine and vomit.

  • Three Ebola vaccines in development amid growing outbreak fears

    Three Ebola vaccines in development amid growing outbreak fears

    A rapidly spreading outbreak of a rare, lethal strain of Ebola, the Bundibugyo species, has sparked an urgent global push to develop targeted vaccines, with three leading research and industry groups racing to deliver viable candidates to stem a crisis that has already claimed nearly 250 lives. Public health experts warn this outbreak, which emerged undetected in a conflict-stricken region of the Democratic Republic of Congo (DRC) with severely limited healthcare infrastructure, could become the most devastating Ebola event on record, rivaling the 2014–2016 West African crisis that killed more than 11,000 people.

    As of the latest update, more than 1,000 suspected Bundibugyo Ebola cases have been recorded in the DRC, with nine confirmed cases already detected in neighboring Uganda, raising fears of cross-border spread. Unlike the more common Zaire Ebola strain, for which an approved vaccine already exists, Bundibugyo is one of six known Ebola species that has only caused two documented outbreaks in history, and no licensed countermeasures currently exist for it.

    The Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding to all three ongoing vaccine development projects, with CEPI CEO Dr Richard Hatchett emphasizing that “every day counts” in the race to contain the virus. Each project leverages different cutting-edge vaccine technologies, many refined and proven during the global COVID-19 pandemic, to target the unique glycoprotein structure on the surface of the Bundibugyo virus.

    The International Aids Vaccine Initiative (IAVI) is leading one effort, adapting the existing approved Zaire Ebola vaccine to target the new strain. Preclinical testing in non-human primates has already shown promising results: the modified candidate rapidly primes the immune system and delivered nearly 100% protection against Bundibugyo. IAVI president and CEO Dr Mark Feinberg noted that while early data leaves his team optimistic about the vaccine’s potential, the candidate currently remains seven to nine months away from entering human clinical trials, though researchers are working aggressively to shorten that timeline. Feinberg echoed widespread public health warnings, saying the outbreak “is clearly threatening to be as severe an outbreak as [the 2014–2016 West African event], if not even worse”, making vaccine development an urgent global priority. That assessment aligns with warnings from medical charity Médecins Sans Frontières, which has described the situation as “deeply alarming”, noting the outbreak has already produced more confirmed cases in its early stages than any previous Bundibugyo event.

    A second candidate is being developed by US pharmaceutical giant Moderna, which is drawing on its mRNA technology that enabled rapid vaccine development during the COVID-19 pandemic. Moderna CEO Stéphane Bancel said the company would “move with urgency and scientific rigor to support the response and help bring a potential vaccine closer to the communities that need it most”.

    The third candidate is being developed by the University of Oxford, which also adapted its established viral vector vaccine platform – first used at scale for COVID-19 – to create a new targeted Ebola vaccine. The Oxford team projects their candidate will be ready for human clinical trials in just two to three months, a significantly faster timeline than the IAVI project.

    While all three candidates are designed to train the human immune system to recognize the Bundibugyo glycoprotein, they use distinct technological approaches: IAVI’s candidate uses a live, harmless engineered virus that displays the Ebola glycoprotein to teach the immune system to recognize the threat, while both Moderna’s mRNA vaccine and Oxford’s viral vector vaccine deliver a small fragment of genetic code that instructs the body’s own cells to produce the glycoprotein, triggering an immune response. Differences in how these technologies activate the immune system may impact the level of protection they provide or the number of doses required, so all candidates will require rigorous testing in human clinical trials to confirm safety and efficacy. The outbreak has already drawn widespread concern from global health bodies, with World Health Organization director general Dr Tedros Adhanom Ghebreyesus noting that a safe, effective Bundibugyo vaccine would not only help control the current crisis but also strengthen global preparedness for future outbreaks of this rare but deadly pathogen.

  • Confirmed Ebola cases in Congo reach 282 as survivors describe their recoveries

    Confirmed Ebola cases in Congo reach 282 as survivors describe their recoveries

    BUNIA, Democratic Republic of Congo – In an update released Sunday evening, Congolese health authorities confirmed that the ongoing Ebola outbreak in the country’s eastern region has reached 282 confirmed cases, as survivors of the virus share stories of unexpected recovery that have offered a glimmer of hope amid widespread response challenges.

    The vast majority of infections – 264 of the total confirmed cases – are concentrated in Ituri province, the epicenter of the current outbreak. Nationwide, more than 1,000 additional suspected cases are being investigated, with the pathogen identified as the Bundibugyo strain of Ebola, a rare variant for which no universally approved vaccine or targeted treatment currently exists.

    Congolese health officials outlined the core barriers halting effective containment of the virus. Key challenges include timely detection of new infections and rapid isolation of positive cases, thorough contact tracing of exposed individuals, implementation of safe, culturally respectful burials for virus victims, and bolstering infection control protocols at local health facilities. To date, only 45% of required contact tracing has been completed, with 220 suspected cases still undergoing testing and verification.

    Against this difficult backdrop, the five people confirmed to have recovered from the strain – all of whom work in the health sector, including four nurses and one laboratory technician, the group most heavily impacted by the outbreak so far – have opened up about their experiences, describing overwhelming relief at surviving the deadly disease.

    Baraka Bulambulu, one of the recovered nurses, shared that he felt indescribable joy after his final two consecutive Ebola tests returned negative results. Bulambulu was among the survivors honored with recovery certificates by World Health Organization Director-General Tedros Adhanom Ghebreyesus during the opening ceremony of a new Ebola treatment center in Bunia, Ituri’s provincial capital, on Sunday. “My first test came back positive, but the second and third were negative,” Bulambulu said, smiling as he spoke. “Coming out of this illness alive is a joy that cannot be put into words.”

    Another recovered nurse, Ezo Étienne, recalled how his symptoms first emerged while he was completing routine ward rounds checking on patients at his hospital. “That was how it started,” he said. “I called the response team and told them something was wrong. I checked my blood pressure and saw I had immediate hypotension. I decided to rest for a few minutes, and shortly after I began vomiting.”

    To date, all clinical care for infected patients has focused on managing symptoms, as no targeted antiviral treatment for the Bundibugyo strain is yet approved for widespread use. Speaking to the recovered health workers at the treatment center opening, Tedros emphasized that their survival carries a powerful message for the response effort. “Your courage gives hope, and your living story proves that this outbreak can be stopped,” he told the group.

    Neighboring Uganda has already confirmed nine cases of Ebola linked to the Congolese outbreak, and has closed its shared border with Congo in an effort to slow cross-border transmission.

    While the DRC and Uganda have recorded more than 20 previous Ebola outbreaks across the region, the Bundibugyo strain remains extremely rare. Complicating the current response beyond the lack of approved medical countermeasures are the remote location of outbreak hotspots and ongoing armed violence in the eastern DRC that hinders aid access. Despite these significant hurdles, senior Congolese health leaders say the recoveries mark an important milestone.

    These five recoveries are “a victory worth celebrating,” said Dr. Dieudonne Mwamba Kazadi, director-general of the DRC’s National Institute of Public Health. He added that the outcomes send a clear message: “It is possible to recover from Ebola when you seek care early at a dedicated treatment facility.”

  • DR Congo celebrates recovery of Ebola survivors

    DR Congo celebrates recovery of Ebola survivors

    In a hopeful turning point for the ongoing Ebola outbreak centered in the Democratic Republic of the Congo’s (DRC) eastern Ituri province, five infected patients have officially recovered and been discharged from medical care, drawing praise from global and national health authorities. Four of the newly discharged survivors are frontline nurses, honored at a public ceremony held Sunday in Bunia, Ituri’s provincial capital, while the first recovered patient – a laboratory worker – was released last week.

    Speaking directly to the four nurse survivors during his visit to Bunia, World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus highlighted the profound symbolic power of their recovery. “You are living proof that this outbreak can be stopped,” he told the group, which includes three men and one woman. Acknowledging the heavy toll the outbreak has already taken on frontline medical staff, Dr. Tedros added, “It pains me to see health workers who have already died because of Ebola while serving others… this is the risk which comes with the profession, but your commitment to coming back to serve means a great deal.” Each survivor received a formal certificate recognizing their recovery at the ceremony.

    For the survivors, the experience of infection and isolation was deeply challenging. Nurse Etienne Ezo, one of the discharged nurses, shared his candid reflection with Reuters, saying, “We were really demoralized because we thought at any moment we would die. If you have never been isolated, you cannot understand how hard that experience is.”

    National health officials echoed Dr. Tedros’ optimism, framing the recoveries as a clear validation of existing response strategies. DRC’s Institute of Public Health wrote on social media that this encouraging milestone confirms the effectiveness of core field interventions: early detection of cases, timely clinical care, comprehensive contact tracing, and active community engagement. The institute’s director, Dr. Mwamba Kazadi, called the recoveries a victory worth celebrating, emphasizing that early diagnosis and high-quality care directly improve patient outcomes. Health officials stress this outcome should encourage anyone who suspects they have contracted Ebola to seek medical care immediately.

    The latest outbreak, the 17th recorded Ebola outbreak in DRC history, is caused by the Bundibugyo strain of the virus, for which no widely approved vaccine currently exists – though development of targeted vaccines is ongoing. As of the latest update, more than 1,000 suspected cases have been recorded in DRC, with at least 246 deaths linked to the outbreak. The virus has spread beyond DRC’s borders: neighboring Uganda has confirmed nine cases and one death, including cases in the capital Kampala, and suspected cases have even been identified outside of Africa. On Saturday, Brazilian health authorities announced they were investigating two potential Ebola cases in São Paulo state.

    Despite this small win, major challenges remain for the outbreak response. Dr. Tedros highlighted persistent barriers including gaps in early case detection and isolation, incomplete contact tracing, difficulties implementing safe and dignified burial practices, infection control gaps in health facilities, and low community awareness in some affected areas. Most notably, community resistance has emerged in some regions, sparked by public health rules that ban traditional family handling of Ebola victims’ bodies to prevent transmission – a regulation that directly clashes with long-held local burial customs. This tension has already led to attacks on health centers by local residents.

    Addressing these challenges, Dr. Tedros and the Congolese government released a joint statement Sunday emphasizing that local communities are “at the heart of the solution” to the outbreak, and that successful response depends on earning community trust and active participation. The joint statement calls on all communities to adopt sustained protective behaviors, including regular hand washing, seeking early medical care at approved facilities when symptoms appear, and sharing accurate public health information to counter misinformation.

    Frontline health workers have borne the brunt of the outbreak’s risk, with many contracting the virus while caring for patients. The recovery of five infected patients, four of them health workers, offers a rare moment of optimism amid a crisis that has already claimed hundreds of lives, and serves as a reminder of the importance of rapid access to care for those exposed.

  • Hundreds of youths protest outside Kenya’s Ebola quarantine center for US citizens

    Hundreds of youths protest outside Kenya’s Ebola quarantine center for US citizens

    On Monday, hundreds of young Kenyan demonstrators gathered outside the gates of Laikipia Air Base in the central town of Nanyuki, rallying against a planned Ebola quarantine facility that was set to host American citizens exposed to the virus. The public demonstration comes just two days after Kenya’s High Court ordered an immediate suspension of the facility’s construction and any incoming foreign patients, pending a full judicial hearing into the case. The legal challenge was filed by two prominent Kenyan groups: the Law Society of Kenya and a national constitutional watchdog, which argue that Kenya’s overstretched, fragile public health system cannot safely accommodate the risks of hosting quarantined Ebola-exposed patients from abroad. The controversial plan first emerged last week, when anonymous U.S. administration officials confirmed to reporters that the U.S. intended to transfer Americans who had contracted Ebola exposure while working or traveling overseas to this new Kenyan facility, rather than repatriating them to the United States. According to those officials, the site at Laikipia Air Base was scheduled to be operational by this Friday, with capacity for 50 quarantine patients. The initiative has sparked widespread pushback across multiple levels of Kenyan society even before it could launch. On Sunday, Kenya’s Health Minister Aden Duale attempted to ease public tensions, stating that the facility would be open to “everyone” rather than being reserved exclusively for U.S. nationals. But this clarification has done little to alleviate local concerns. Joshua Irungu, the governor of Laikipia County, has publicly joined the opposition, noting that dozens of local residents work on the air base and would face unavoidable exposure risks if the quarantine center opens. For its part, the U.S. has sought to frame the initiative as a contribution to Kenyan public health: U.S. Secretary of State Marco Rubio announced in an official statement that the U.S. government would allocate $13.5 million to support Kenya’s overall Ebola preparedness efforts as part of the plan. Currently, Kenya itself has not recorded any confirmed cases of Ebola, but the threat is close to home. Neighboring Uganda has already confirmed nine cases and closed its border with the Democratic Republic of Congo, where the current outbreak is centered. The DRC has reported at least 282 confirmed cases of the Bundibugyo strain of Ebola, with more than 1,000 additional suspected cases. Critically, this specific strain of the virus has no approved vaccine or targeted treatment available, amplifying global and local concerns about accidental spread. The ongoing legal challenge, public protest, and conflicting statements from Kenyan and U.S. officials have left the future of the quarantine project hanging in limbo as regional authorities work to contain the spreading outbreak.

  • Patients find help with therapy donkeys at psychiatric hospital near Paris

    Patients find help with therapy donkeys at psychiatric hospital near Paris

    In the quiet, tree-lined grounds of Ville-Evrard hospital, just outside Paris in Neuilly-sur-Marne, a one-of-a-kind mental health treatment program is changing patients’ lives through an unlikely partner: calm, gentle therapy donkeys. Housed in restored 19th-century farm buildings, this specialized unit blends the restorative power of nature with the intuitive emotional intelligence of animals to offer a complementary form of care that stands alone in France today.

    On a recent Friday session, patients walked the site’s wooded paths alongside the program’s five donkeys — Nono, Pitou, Oscar, Manolo and Malraux — learning to groom the animals, clean their hooves, and build quiet, trusting bonds. Many participants left the session with soft hugs for their donkeys, visibly relaxed after hours of interaction away from traditional hospital treatment routines. For 60-year-old patient Nathalie, the impact of the sessions matches that of her anxiety-relieving medication. “I’d call it animal medicine,” she explained, speaking under a first-name-only agreement to protect her privacy. “It brings relief. You stop thinking about everything else.”

    The program, which is fully covered by France’s public health system, is offered to patients at no extra cost as part of their personalized treatment plans. Nurse Audrey Seffar, who works on the unit, highlighted Nathalie’s remarkable progress over just a handful of sessions. When she first joined, Nathalie, who experiences physical difficulties, would not leave the mobility cart provided for her. But with gentle encouragement from staff and the quiet presence of her paired donkey, she gradually gained the confidence to stand and walk alongside the animal. “The animal serves as a mediator,” Seffar explained. “It’s such an extraordinary one that today she was able to leave the cart and stand beside her donkey.”

    For 52-year-old patient Jérôme, the program has cut through the deep loneliness that often accompanies chronic mental illness. “Talking with people, taking part in activities I wouldn’t normally do, it helps me in my daily life,” he said. “It helps you break away from the routine of treatment and medication. Staying at home isn’t good for me.”

    The groundbreaking initiative first launched in 2016, spearheaded by psychiatric nurse Ermelinda Hadey and her husband François Hadey. Ermelinda had long advocated for the value of animal-assisted therapy, and identified donkeys — known for their naturally calm, social demeanor — as ideal candidates for the work. François trained the animals specifically for therapy interactions, and many of the donkeys themselves were adopted from animal shelters after surviving neglect or mistreatment, creating an unspoken shared understanding with patients navigating trauma.

    François Hadey notes that donkeys’ unique temperament makes them perfect for this work: “A donkey is very intelligent. It understands things very quickly, but you have to explain slowly. Donkeys are calm, serene animals that are generally close to people. Once they’re involved in these interactions, they connect very well with patients. They’re emotional sponges.”

    In 2022, the program earned official status as a dedicated health care unit within the hospital, enabling it to hire three full-time nursing staff, with additional support from volunteers with a local nonprofit that helps care for the animals. It has since expanded beyond donkeys to add a range of other small animals, including guinea pigs, chickens, doves, goats, turtles and rabbits. Sessions are tailored to each patient’s ability and needs, with smaller animals able to be brought directly to the rooms of patients who cannot leave their beds.

    Eighteen-year-old nursing student Alicia Fabi, who regularly participates in the sessions, says the program offers patients a much-needed break from the structured hospital environment. “Every time we come back from the activity, they say they feel good, calm and relaxed, and that they enjoyed the outing. That’s really positive,” she explained. Walking and working alongside the animals also allows care teams to build deeper, more trusting relationships with patients outside of clinical conversations. “We talk about many different things, their illness, their lives and just about everything else. We don’t focus only on the illness because we don’t want them dwelling on it all the time,” Fabi added.

    The program is designed to treat a wide range of mental health conditions, including anxiety, depression, autism spectrum disorder, schizophrenia, and other mood and personality disorders. Care teams report consistent improvements in patients’ emotional regulation, communication skills, social interaction, and self-esteem. Even small daily tasks with the animals double as therapeutic work: when patients help feed and groom the donkeys, those habits translate to improvements in their own self-care, Ermelinda Hadey explained. “Everything we do with the animals allows us to work with the patient,” she said. “We work on feeding the animal, which helps us address the patient’s own eating habits. We work on the animal’s hygiene, and by mirror effect, we work on the patient’s hygiene as well.”

    Many participants take intensive prescription medications, including antipsychotics and sedatives, that can leave them feeling unmotivated to engage in activities. Hadey says the connection with the animals cuts through that fog, giving patients a reason to show up and participate. Crucially, the program does not replace traditional psychiatric care or medication, but acts as a complementary support to help patients regain confidence and a sense of self-worth.

    Now, the team behind the program is pushing for formal recognition from the global psychiatric community, and is calling for targeted scientific research to document the long-term benefits of donkey-assisted therapy. While hundreds of patient anecdotes and daily observations from care staff confirm the program’s positive impact, formal clinical research is needed to cement its status as a evidence-based complementary treatment. “To do that, we need research. We have plenty of accounts from patients … Caregivers who accompany them see the benefits every day as well. But doctors have so many other responsibilities that they don’t necessarily witness it firsthand,” Hadey explained. For the staff that works on the unit every day, though, the proof is already clear: as one nurse put it at the end of Friday’s session, “Donkeys are my best colleagues.”

  • Brazil monitors two patients for possible Ebola infection

    Brazil monitors two patients for possible Ebola infection

    Brazilian health authorities have launched active monitoring protocols for two suspected Ebola cases located in the nation’s two largest urban centers, São Paulo and Rio de Janeiro, as a growing outbreak of the rare virus continues to spread across Central Africa.

    According to officials from São Paulo’s state government, a 37-year-old male traveler from the Democratic Republic of Congo (DR Congo) has developed Ebola-compatible symptoms, most notably a persistent fever. Across the country in Rio de Janeiro, state health officials activated full safety protocols after a Belgian traveler arriving from Uganda presented with common viral Ebola symptoms including cough, body chills, and diarrhea.

    Preliminary diagnostic results for both patients are scheduled to be released next week. If either tests positive for the virus, they will mark the first confirmed Ebola infections detected outside of Africa since the current outbreak began in DR Congo.

    As of this update, the outbreak has already caused severe public health damage across Central Africa: DR Congo has recorded more than 1,000 suspected Ebola cases, with at least 246 confirmed deaths linked to the virus. Neighboring Uganda has confirmed nine cases and one fatality connected to the outbreak.

    This outbreak is driven by the rare Bundibugyo strain of Ebola, a pathogen that currently has no widely approved or proven vaccine. The strain kills roughly one-third of all people it infects.

    While both patients are being monitored for Ebola, existing testing has already identified alternative diagnoses: the DR Congolese traveler in São Paulo tested positive for meningitis and remains in serious condition, while the Belgian traveler in Rio de Janeiro received a positive malaria diagnosis. Brazilian public health officials emphasize that these existing diagnoses do not rule out concurrent Ebola infection.

    Ebola is a zoonotic virus that typically circulates in wild animal populations, most commonly fruit bats. Human outbreaks most often begin when people handle or consume meat from infected animals. Once a human is infected, the virus spreads to other people through direct contact with an infected person’s bodily fluids, including sweat, saliva, blood, semen, feces, urine, and vomit.

    Over the weekend, the international medical charity Médecins Sans Frontières (MSF) issued an urgent warning about the outbreak’s trajectory, saying the virus’s fast spread has created an “alarming situation.” The organization noted that the current outbreak has already seen an unprecedented number of cases recorded just a short time after it was first detected.

    World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus is currently on a visit to Ituri province in DR Congo, the region hardest hit by the outbreak, where he is meeting with response teams and overseeing local containment efforts. Even with the suspected cases now being monitored outside of Africa, the WHO has repeatedly emphasized that large-scale global spread of the virus remains highly unlikely.

  • WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo

    WHO chief hails 5 Ebola recoveries as a new treatment center opens in eastern Congo

    BUNIA, Democratic Republic of Congo – On a Sunday visit to this Ituri provincial capital at the center of an ongoing rare Ebola outbreak, World Health Organization Director-General Tedros Adhanom Ghebreyesus announced a small, hopeful milestone: five patients have successfully recovered from infection with the Bundibugyo virus, a rare strain of Ebola with no approved vaccine or specific treatment.

    Tedros made the announcement during the official inauguration of a new Ebola treatment facility in Bunia, noting that four of the recovered patients would be discharged on the day of his announcement, with a fifth having been released two days prior. The first confirmed recovery of a Bundibugyo patient in this current outbreak was documented by WHO just two days earlier, a breakthrough that health officials are emphasizing to counter widespread public fear around the often-fatal virus.

    “Of course, we’re still working on developing targeted vaccines and treatments, but that doesn’t mean that people cannot recover from Ebola,” Tedros told attendees at the opening event. He stressed that early care seeking is critical to survival, urging community members to access medical support immediately after developing symptoms. “If you come to health facilities when you have symptoms, you can get the support and recover, so the key is to come forward as early as possible and to get the necessary support,” he added.

    As of the latest official counts, the outbreak has recorded 906 suspected cases and 223 suspected deaths across the Democratic Republic of Congo. The outbreak has already spilled over into neighboring Uganda, where the Ugandan Ministry of Health confirmed nine cases and one death as of last Friday.

    Despite the opening of new treatment infrastructure and the arrival of additional international aid, the virus is still spreading faster than public health responders can contain it, medical aid organization Doctors Without Borders (MSF) warned in a statement Saturday. The group called for urgent expansion of diagnostic testing, faster deployment of trained outbreak response personnel, and guaranteed consistent access for medical supply shipments into affected regions.

    Response efforts face two major layers of security and community barriers. First, long-running local conflict over access to health measures: local residents have expressed intense anger over mandatory Ebola body management protocols, which conflict with traditional local burial customs. This public frustration has boiled over into at least three separate attacks on local health centers, putting response teams at severe risk. Second, widespread armed conflict across eastern Congo has further disrupted operations. In Ituri, the Islamic State-aligned Allied Democratic Forces rebel group carries out regular attacks, while to the south in the North Kivu and South Kivu provinces – where the outbreak has also been detected – the Rwanda-backed M23 rebel militia controls major urban centers including Goma and Bukavu. Two cases have already been recorded in areas under M23 control.

    To overcome these barriers, Tedros emphasized that sustained community engagement is non-negotiable for a successful response. “We can stop this Ebola and anyone who has it can also recover. But the rule … is this thing is everybody’s business and every citizen should be involved,” he said.

    Local health leaders echoed the call for collective action while leaning into the recent recovery news to reinforce public hope. “The final message we would like to share with the Ituri community is that there is hope,” said Pierre Akilimali, Incident Manager at Congo’s National Institute of Public Health, during the treatment center’s inauguration. “With the symptomatic treatment that we are currently providing, we are seeing patients recover.”

    Davin Ambitapio, a senior doctor at the new Bunia facility, added that the outbreak is far from insurmountable with coordinated support. “We truly have hope. The virus here is not as complicated as those we have dealt with in the past, and with the support of all our partners, we believe we will be able to bring this outbreak under control as quickly as possible,” he said.

    Reporting for this story was contributed by Banchereau from Dakar, Senegal.

  • Ebola spread in DR Congo ‘alarming’, charity warns, as WHO chief visits worst-hit area

    Ebola spread in DR Congo ‘alarming’, charity warns, as WHO chief visits worst-hit area

    Two weeks after the Democratic Republic of Congo officially declared an Ebola outbreak, international medical and public health authorities are sounding the alarm over an unprecedented rate of spread that has outpaced current response efforts. The epicenter of the outbreak is the northeastern Congolese province of Ituri, where transmission has already outstripped every recorded early-stage Ebola event in modern history.

    In a public statement released Saturday, Dr. Alan Gonzalez, deputy director of medical humanitarian organization Médecins Sans Frontières (MSF), described the unfolding situation as deeply alarming. “Never before has an Ebola outbreak recorded so many cases so soon after its declaration,” Gonzalez emphasized, adding that frontline MSF teams on the ground have observed that response operations have not yet matched the speed of the virus’s advance. He warned that the full extent of the crisis remains unclear: hundreds of test samples from suspected patients are still backlogged and unprocessed, even as new potential infections are reported every single day.

    Gonzalez also outlined significant logistical barriers delaying critical containment work and aid delivery, pointing to widespread border and airport closures as major disruptive constraints. These challenges compound long-standing issues created by ongoing armed conflict in the region, which the World Health Organization (WHO) has repeatedly flagged as a major barrier to mounting an effective response.

    As of the latest updates, more than 1,000 suspected Ebola cases have been recorded across DR Congo, with at least 246 confirmed deaths linked to the outbreak. The virus has also spilled over the country’s northern border into neighboring Uganda, where nine confirmed cases and one fatality have been reported to date.

    Over the weekend, WHO Director-General Dr. Tedros Adhanom Ghebreyesus traveled personally to Ituri to oversee and assess local containment efforts. Speaking after his arrival, Tedros explained that the WHO delegation was in the province to evaluate response progress and address unmet needs that are slowing control work. He called for greater engagement of local communities in outbreak response, noting that residents have on-the-ground knowledge that is critical to successfully curbing transmission. “They understand the problems better and they know the solution as well,” he said of local populations.

    One of Tedros’ first official stops during the visit was the National Institute for Biomedical Research laboratory in Bunia, Ituri’s provincial capital, where all samples from suspected Ebola patients are now processed. Local health authorities confirmed that the newly operational local testing facility can deliver confirmed results to care teams within 24 hours, a major improvement that allows clinicians to quickly isolate infected patients and initiate life-saving care. Prior to the opening of this lab, samples had to be transported more than 1,500 kilometers to Kinshasa, DR Congo’s capital, for testing — delays that put communities at greater risk of further spread and cost vulnerable patients critical care time.

    The current outbreak is caused by Bundibugyo, a rare strain of Ebola for which no widely proven vaccine currently exists. The virus has an average case fatality rate of roughly one-third, meaning approximately one in every three infected people will die from the disease. Like all Ebola strains, Bundibugyo originally circulates in wild animal populations, most commonly fruit bats; human outbreaks typically begin when people come into contact with or consume meat from infected animals.

  • WHO chief visits epicenter of the Ebola outbreak in eastern Congo as cases outpace response

    WHO chief visits epicenter of the Ebola outbreak in eastern Congo as cases outpace response

    Amid an unprecedentedly rapid resurgence of a rare Ebola variant in the Democratic Republic of the Congo’s eastern region, World Health Organization Director-General Tedros Adhanom Ghebreyesus traveled Saturday to Bunia, the urban center at the heart of the ongoing outbreak, to assess response efforts and engage with frontline stakeholders.

    The rare Bundibugyo strain of Ebola driving this outbreak has no officially approved vaccine or targeted treatment, putting global and local health teams in an unenviable position as they work to slow transmission. Official WHO data puts the current count at 906 suspected cases and 223 suspected deaths across the DRC, with neighboring Uganda confirming nine cases and one fatality as of Friday, according to Uganda’s ministry of health.

    During his visit, Tedros was scheduled to tour a local Ebola treatment facility, hold talks with provincial and national government leaders, and speak directly to frontline health workers and families directly impacted by the virus. Speaking to reporters Friday after a meeting with DRC Prime Minister Judith Suminwa Tuluka, Tedros emphasized that containing the outbreak requires directing every possible resource to the epicenter. “This is a difficult situation, and we recognize that. But the Democratic Republic of Congo has faced the Ebola virus many times before. We are confident that it can once again bring this outbreak under control,” he noted.

    Fresh international aid has begun arriving in recent days: the European Union dispatched a shipment of medical supplies to Ituri province, where Bunia is located, on Thursday, with additional shipments on the way. The United States also announced an additional $80 million in emergency aid the same day, bringing Washington’s total commitment to response efforts to more than $112 million. On the ground, Associated Press reporters observed that response coordination at Bunia’s Rwampara Clinic and General Hospital has improved, with expanded staffing, additional personal protective equipment and critical medical supplies now in place — even as new patients continue to arrive around the clock.

    Despite these incremental gains, emergency medical groups warn that response efforts are still failing to keep up with the fastest-moving Ebola outbreak recorded in modern history. In a statement released Saturday, Doctors Without Borders (MSF) Deputy Operations Director Dr. Alan Alan Gonzalez underscored the severity of the gap, saying: “Never before has an Ebola outbreak recorded so many cases so soon after its declaration. Nobody knows the true scale and severity of this outbreak.” Gonzalez called for urgent action to expand testing capacity, speed up the deployment of trained response personnel, and secure uninterrupted, consistent access to critical medical supplies across affected areas.

    Multiple overlapping barriers continue to derail response work. Local resentment over strict Ebola body management protocols, which conflict with traditional local burial customs, has already spurred at least three separate attacks on health facilities treating patients, putting frontline workers at extreme risk. Ongoing armed conflict in the region further complicates access: the Allied Democratic Forces, a rebel faction with ties to the Islamic State, and a coalition of ethnic militias carry out regular attacks across Ituri. The outbreak has also spread south to the North Kivu and South Kivu provinces, where the Rwanda-backed M23 rebel group controls major population centers including Goma and Bukavu. Two cases have already been recorded among rebel-held territories there.

    In response to the cross-border spread of the virus, both Uganda and Rwanda have sealed their borders with the DRC, and the Trump administration last week implemented an entry ban on non-U.S. passport holders who have recently traveled to the DRC, Uganda or South Sudan. Tedros pushed back against these restrictive measures Friday, arguing that border closures and travel bans do nothing to stop transmission and actually undermine transparency. “Closing borders, as some countries have done, only discourages transparency. The Democratic Republic of Congo is reporting the situation openly and transparently,” he said, urging governments that have implemented restrictions to reverse course.

    This report was contributed to by AP reporters based in Dakar, Senegal and Bonn, Germany.